AWM
ABBV icon

Adams Wealth Management’s AbbVie ABBV Stock Holding History

Adams Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Buy
3,177
+212
+7% +$45.6K 0.15% 85
2026
Q1 		$645K Buy
2,965
+195
+7% +$43.3K 0.14% 79
2025
Q4 		$633K Sell
2,770
-162
-6% -$36.9K 0.14% 81
2025
Q3 		$679K Sell
2,932
-394
-12% -$80.2K 0.15% 79
2025
Q2 		$617K Sell
3,326
-1,613
-33% -$300K 0.12% 83
2025
Q1 		$1.03M Sell
4,939
-339
-6% -$65.9K 0.2% 66
2024
Q4 		$938K Buy
5,278
+565
+12% +$104K 0.18% 65
2024
Q3 		$931K Sell
4,713
-301
-6% -$56.2K 0.2% 62
2024
Q2 		$860K Sell
5,014
-994
-17% -$165K 0.2% 58
2024
Q1 		$1.09M Sell
6,008
-554
-8% -$95.5K 0.27% 56
2023
Q4 		$1.02M Sell
6,562
-111
-2% -$16.2K 0.3% 55
2023
Q3 		$995K Sell
6,673
-728
-10% -$107K 0.34% 50
2023
Q2 		$997K Buy
7,401
+316
+4% +$46.3K 0.31% 57
2023
Q1 		$1.13M Buy
7,085
+672
+10% +$103K 0.36% 38
2022
Q4 		$1.04M Buy
6,413
+330
+5% +$50.6K 0.37% 30
2022
Q3 		$816K Sell
6,083
-432
-7% -$62K 0.31% 34
2022
Q2 		$998K Sell
6,515
-261
-4% -$39.9K 0.38% 21
2022
Q1 		$1.1M Sell
6,776
-484
-7% -$70.3K 0.36% 19
2021
Q4 		$983K Sell
7,260
-738
-9% -$87.2K 0.29% 26
2021
Q3 		$863K Sell
7,998
-1,208
-13% -$138K 0.33% 28
2021
Q2 		$1.04M Sell
9,206
-193
-2% -$21.7K 0.44% 24
2021
Q1 		$1.02M Buy
9,399
+114
+1% +$12.2K 0.47% 21
2020
Q4 		$995K Sell
9,285
-496
-5% -$47.7K 0.63% 19
2020
Q3 		$857K Sell
9,781
-103
-1% -$9.7K 0.67% 20
2020
Q2 		$970K Sell
9,884
-257
-3% -$22.6K 0.99% 13
2020
Q1 		$773K Sell
10,141
-569
-5% -$48.5K 0.97% 21
2019
Q4 		$948K Buy
+10,710
New +$889K 0.8% 39

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Adams Wealth Management's ABBV Position: Q2 2026 in Review

Adams Wealth Management increased its AbbVie (ABBV) stake by 7.2% in Q2 2026, buying an estimated $45.6K and bringing the position to 3,177 shares worth $799K. The position accounts for 0.15% of the portfolio, ranked #85.

Adams Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.13M in Q1 2023. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Adams Wealth Management held 3,177 shares of AbbVie worth $799K as of Q2 2026.
  • Adams Wealth Management bought 212 AbbVie shares in Q2 2026, an estimated $45.6K.
  • AbbVie made up 0.15% of Adams Wealth Management's portfolio in Q2 2026, its #85 holding.
  • Adams Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Adams Wealth Management's AbbVie position peaked at $1.13M in Q1 2023.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Adams Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.